SciClone Pharmaceuticals Story

SciClone Pharmaceuticals Inc -- USA Stock  

USD 11.15  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for SciClone Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on SciClone Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for SciClone Pharmaceuticals. Also please take a look at World Market Map.
Sale by Hong Zhao of 12500 shares of SciClone Pharmaceuticals
Filed transaction by Sciclone Pharmaceuticals officer. General open market or private sale of non-derivative or derivative security

SciClone Pharmaceuticals Inc insider trading alert for sale of common stock by Hong Zhao, CEO China Operations, on January 3, 2018. This event was filed by Sciclone Pharmaceuticals with SEC on 2017-06-14. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for SciClone Pharmaceuticals

Comparing Sophiris Bio and SciClone Pharmaceuticalsnews
The Ledger Gazette - Jan 20, 2018 SciClone Pharmaceuticals logo SciClone Pharmaceuticals, Inc. is a pharmaceutical company. The Company product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders.
over a week ago at http://stocknewstimes.com 
JPMorgan Chase and Co. Buys 15356 Shares of SciClone Pharmaceuticals, Inc ...
news
SciClone Pharmaceuticals logo JPMorgan Chase and Co. raised its position in shares of SciClone Pharmaceuticals, Inc. by 2.4 percent during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC ...
over a week ago at http://baseballnewssource.com 
SciClone Pharmaceuticals Earns Coverage Optimism Score of 0.25
news
BBNSFull coverage

Did you try this?

Run Aroon Oscillator Now
   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Hide  View All  NextLaunch Aroon Oscillator

Current Valuation

Current Valuation Comparative Analysis
  Current Valuation 
      SciClone Pharmaceuticals Comparables 
SciClone Pharmaceuticals is currently under evaluation in current valuation category among related companies. Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.